featured
Retreatment Rates Following Anti-VEGF Therapies and Laser for Retinopathy of Prematurity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept and Laser for Retinopathy of Prematurity
Ophthalmology 2022 Jul 13;[EPub Ahead of Print], ET Chang, AS Josan, R Purohit, CK Patel, K XueFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.